Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How do you know that?
Can you please give us the newest sales figures then!
Price-Rite != Buy Rite
This store, you've called is NOT listed.
Of course, nobody knows …
All locations, where you'll able to get it:
http://www.kamasutraspirit.com/locations.html
Bar & Nightclub Convention and Trade Show
March 19 - 21
Las Vegas Bar & Nightclub Convention TS
Oh gordonhoochie, still not sold your shares and still angry?
139000 vol and up 15.38%...............wow!!
Kamasutra on Youtube
All videos about the Kamasutra Vodka.
Kamasutra Spirit
Kamasutra™ Exotic Vodka With Natural Herbs Customer Testimonial
will be unveiled today at the largest Buy-Rite store in New Jersey
means that they will start with the promo in this store today
not on the Buy-Rite Online Store
Real-Time Best Bid & Ask 0.0034 / 0.0037
go $HBRM
Hmmm, we have some L2 premarket activity
Real-Time Best Bid & Ask 0.004 / 0.0045
This huge!
DiamondsAndHeels14 has 246.641 subscribers
http://www.youtube.com/user/DiamondsAndHeels14
The video has surpassed 10'000 views already
Lets get the powerhour begin
FINRA Call Center: (301) 590-6500
$0.0058 15,715 OTO 09:30:00
we need to pass the 0.0051 somehow
a bit more volume --> up up it goes
Here we go! Big blocks comin in! Weeee :)
Maybe the last chance to get some cheapies!
Vodka should be released this month
See here:
http://ih.advfn.com/p.php?pid=nmona&article=52286092
Here we go! 0.0053 / 0.0056 +27.28%
Do we see 0.0065 ? GO $HBRM!!
Real-Time Best Bid & Ask 0.0051 / 0.0052
GO $HBRM
Real-Time Best Bid & Ask 0.0054 / 0.0059
Let's go $HBRM
100% agree! Go $HBRM
Just ignore him.
He is trying to get some attention, to scare people so he can swollow
shares cheaper …
Look at his board history, just the common nonsense.
If deal goes through and the pps reaches 0.02
this would be quiet tempting to drop. Maybe I will
But who knows ...
I don't see that either.
But keep in mind, all the synergies that will have, if this goes through.
If the buyout price is 0.02, I'll be happy
dreamer ... shares of course
Big order 1m just came in …
You need to see this from a different point of view!
How important is this deal to CHRI?
Therefore how much money they are willing to pay to get into to the US market?
Is this the calm before the storm?
News! China Health Resource Forwards Final Termsheet for Acquision of Herborium Group
China Health Resource Forwards Final Termsheet for Acquision of Herborium Group
PR Newswire
SUINING, China, June 5, 2012
SUINING, China, June 5, 2012 /PRNewswire-Asia/ -- China Health Resource, Inc. (OTCBB: CHRI), today announced it has issued a final termsheet to Herborium Group (OTC Pinksheets: HBRM) and is now awaiting response from the Herborium Board of Directors.
Steve Weiss, USA Director of Strategic Acquisitions and Financial Marketing stated, "I am most excited to have united and introduced both CHRI with HBRM and my hope is for a favorable outcome. As CHRI revenues continue to significantly break all time new highs in their TCM products in China it is my hope that these products will be introduced to all natural western markets with new domestic distribution channels."
"We are proceeding with our Go Global Initiative which includes setting-up headquarter operations in the USA and expansion into other key regions like Latin America and Africa where we find opportunities to grow our business," says Jiayin Wang, CEO of CHRI.
Press Contact:
Mr. Steven WeissContact Tel. 732-513-6921(USA)USA Rep for China Health Resource, Inc. Email: info@chinahealthresource.comwww.chinahealthresource.com
About CHRI
China Health Resource, Inc. engages in the development, manufacturing, processing, marketing and sale of raw and pharmaceutical TCM products including Dahurian Angelica Root (DAR) and Rhizoma Gastrodiae and is the only the provider of GAP quality DAR in the People's Republic of China under the registered Trademark Chuan Baizhi™. DAR, which is also known as "Bai Zhi" in Mandarin Chinese, is an herb that is employed as an ingredient in medicine, cosmetics and food, as well as used in TCM for the treatment of pain, swelling and pustule. The Company's DAR-related products include the Bailing Capsule, Yisheng Capsule, Kimchee-Mate and Fragrant Bag, all of which are sold through regional distributors. The Company was founded in 2001 and is based in Suining, Sichuan Province.
For more information visit www.chinahealthresource.com.
Certain statements in this document regarding financial matters, other than historical facts, and statements of our expectations, intentions, plans and beliefs, constitute "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, that are subject to certain events, risks and uncertainties that may be outside our control. The words "believe", "expect", "anticipate", "optimistic", "intend", "will", and similar expressions identify forward-looking statements. The company intends that such proclamations about future expectations, including future revenues and earnings, future business expansion plans, and all other forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results. These and other risks and uncertainties related to our business are described in greater detail in our filings with the Commission. The foregoing information should be read in conjunction with these filings. We disclaim any intention or obligation to update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made.
SOURCE China Health Resource, Inc.
News! Herborium Group to Present to Investment Community at The National Investment Banking Association, Inc. (NIBA) Conference in
Herborium Group, Inc. (HBRM) www.herborium.com is pleased to announce that Management will present the Company's unique Botanical Therapeutics® opportunity and its operating success at the National Investment Banking Association, Inc. (NIBA) meeting in New York City, June 6th-8th, 2012. NIBA is the only national not-for-profit trade association of regional and independent brokerages, investment banking firms, and related capital market service providers. NIBA is a premier forum for quality small capital companies seeking access and exposure to underwriters and broker/dealers in connection with their capital formation, and other financial objectives. Presentations are by invitation and Herborium presents at the general session on Thursday, as well as being scheduled for a number of the One on One Meetings on Friday.
"We are extremely excited to have the privilege to present at the NIBA forum and to share Herborium's Botanical Therapeutics® opportunity as well as the company's operating success with a number of potential financial and business partners. This event provides both a validation of the Company's achievements to date and a great opportunity for developing valuable investment and growth partnerships for the future," noted Dr. Agnes Olszewski, CEO of Herborium.
Since its inception, NIBA member firms have successfully completed some 1000+ equity offerings totaling approximately $10 billion in new capital for America's finest emerging growth companies. The member firms of NIBA represent over 8800 registered representatives and with an estimated $78 billion assets under management.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company uses clinical validation to establish and maintain a differential advantage. The company sales its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com.
One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.
For more information please inquire: Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.
HBRM #10 Most Read Boards Today!
http://investorshub.advfn.com/boards/Most_Read.aspx
Read full story here,
http://ih.advfn.com/p.php?pid=nmona&article=51340015
On the other hand the pps made it today
from 0.0030 to 0.0039 = 30% plus
It seems to be like the situation we had around
0.0015 to 0.0023 with almost the same volume
Hopefully in 5 Days
after CHRI 10Q is out!
This are great news!
Thanks for sharing.
Finally large orders coming in!
People are loading again, nice to see!
Fasten your seatbelt …
Real-Time Best Bid & Ask 0.0155 / 0.0079 ??
L2 is playing again
There is no need to rush
Might be the target for 2morrow